Clinical Trials Directory

Trials / Completed

CompletedNCT01676857

Chemokine Mechanisms in Chronic Pelvic Pain

Status
Completed
Phase
Study type
Observational
Enrollment
147 (actual)
Sponsor
Northwestern University · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to identify biomarkers that can be utilized in the diagnosis of chronic pelvic pain syndrome in men.

Detailed description

Chronic pelvic pain is the hallmark of patients with chronic pelvic pain syndrome (CPPS), a non-bacterial category of prostatitis that is a significant source of morbidity in American men. The cause of CPPS is unknown and there is a lack of convenient biomarkers for diagnosis of this syndrome. This project will examine the expression of biomarkers in expressed prostatic fluid from adult men with and without a diagnosis of CPPS. Thus our specific aim is to validate the use of the chemokines MCP-1 and MIP-1alpha and mast cell tryptase as biomarkers for CPPS in humans and correlate their levels with CPPS symptoms.

Conditions

Timeline

Start date
2010-05-01
Primary completion
2018-01-31
Completion
2019-01-24
First posted
2012-08-31
Last updated
2019-03-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01676857. Inclusion in this directory is not an endorsement.